# Serum Presepsin as Early Predictor for Neonatal Early-onset Sepsis

> **NCT05022043** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 124 (actual)

## Conditions studied

- Neonatal Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** Serum Presepsin

## Key facts

- **NCT ID:** NCT05022043
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-06-15
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2021-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05022043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05022043, "Serum Presepsin as Early Predictor for Neonatal Early-onset Sepsis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05022043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*